HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Histidyl-proline diketopiperazine

HCID 65137
NotesReactions
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
4257-92-5
Standard SMILES
O=C1N[C@@H](Cc2cnc[nH]2)C(=O)N2CCCC[C@@H]12
InChIKey
LCXWQHWWTPOAFI-UWVGGRQHSA-N
Molecular formula
C12H16N4O2
Average molar mass
248.28 g/mol
Monoisotopic mass
248.12732577

Overview

biologically active cpd to which thyrotropin-releasing hormone (TRH) is metabolized; structure; RN given refers to cpd without isomeric designation

Names & identifiers

Preferred name
Histidyl-proline diketopiperazine
IUPAC
(3S,9aS)-3-(1H-imidazol-5-ylmethyl)-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazine-1,4-dione

Names & synonyms

His-pro-dkpHistidyl-proline diketopiperazineHistidyl-proline-diketopiperazinePyrrolo(1,2-a)pyrazine-1,4-dione, hexahydro-3-(1H-imidazol-4-ylmethyl)-, (3S-trans)-RefChem:922996Cyclo(histidyl-prolyl)Histidylproline diketopiperazine(3S,9aS)-3-(1H-imidazol-5-ylmethyl)-3,6,7,8,9,9a-hexahydro-2H-pyrido[1,2-a]pyrazine-1,4-dioneSCHEMBL23928002Q27162262(3S,9aS)-3-(1H-imidazol-5-ylmethyl)-octahydro-1H-pyrido[1,2-a]piperazine-1,4-dione

Database identifiers

CAS
4257-92-5、53109-32-3
PubChem CID
65137

Properties

Computed structural properties

XLogP
-0.1
Topological polar surface area
78.1 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
3
Rotatable bonds
2
Heavy atoms
18
Formal charge
0
Complexity
360

Experimental & physicochemical properties

Physical DescriptionSolid

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.

Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes